Newbury Pharmaceuticals AB (NEWBRY) — Cash Flow Reinvestment Rate
Latest as of February 2026:
0.00x
Newbury Pharmaceuticals AB (NEWBRY) has a Cash Flow Reinvestment Rate of 0.00x as of February 2026, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr2.26 Million. See NEWBRY free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr2.26 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Newbury Pharmaceuticals AB (None–None)
Year-by-year capital reinvestment analysis for Newbury Pharmaceuticals AB. See Newbury Pharmaceuticals AB financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow